Patent · US Active

Lithium cholesterol compositions, including, but not limited to lithium cholesterol sulfate compositions, and methods of treatment for Alzheimer's disease and neurological disorders

US10828312B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Inventors

Jun Tan · Tampa, US
Roland Douglas Shytle · Largo, US
Jinhua Wen · Tampa, US
Darrell Sawmiller · DeLand, US

Key dates

Filing date	Jun 5, 2019
Grant date	Nov 10, 2020
Priority date	—
Expiry date	Jun 5, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In one aspect, the disclosure relates to compositions of lithium cholesterol compositions, including but not limited to lithium cholesterol sulfate compositions which are useful as therapeutic agents. The disclosure also relates to methods of making lithium cholesterol compositions and pharmaceutical compositions comprising therapeutically effective amounts of the lithium cholesterol compositions. The present disclosure also includes methods of treating one or more clinical neurological conditions with the lithium cholesterol compositions, such as Alzheimer's disease, autism spectrum disorder, bipolar disorder, or other neuropsychiatric disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.